LFDLE
TMO icon

La Financiere de L'Echiquier’s Thermo Fisher Scientific TMO Stock Holding History

La Financiere de L'Echiquier’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$61.9M Buy
111,877
+3,667
+3% +$2.1M 2.7% 12
2024
Q1 		$62.9M Buy
108,210
+57
+0.1% +$32K 2.71% 12
2023
Q4 		$57.4M Buy
108,153
+15,147
+16% +$7.33M 2.65% 13
2023
Q3 		$47.1M Sell
93,006
-2,449
-3% -$1.31M 2.44% 14
2023
Q2 		$49.8M Sell
95,455
-3,006
-3% -$1.62M 2.49% 13
2023
Q1 		$56.7M Buy
98,461
+6,164
+7% +$3.47M 2.98% 9
2022
Q4 		$50.8M Buy
92,297
+1,873
+2% +$992K 3.21% 7
2022
Q3 		$45.9M Buy
90,424
+1,401
+2% +$784K 2.91% 8
2022
Q2 		$48.4M Buy
89,023
+3,929
+5% +$2.16M 2.86% 7
2022
Q1 		$50.3M Buy
85,094
+10,482
+14% +$6.02M 2.07% 14
2021
Q4 		$49.8M Sell
74,612
-43,194
-37% -$27M 1.68% 23
2021
Q3 		$67.3M Sell
117,806
-75,127
-39% -$41.2M 2.26% 12
2021
Q2 		$97.3M Buy
192,933
+61,500
+47% +$29M 3.72% 4
2021
Q1 		$60M Buy
131,433
+16,584
+14% +$7.92M 2.43% 12
2020
Q4 		$53.5M Buy
114,849
+17,781
+18% +$8.34M 2.55% 11
2020
Q3 		$42.9M Buy
97,068
+17,238
+22% +$7.12M 2.97% 13
2020
Q2 		$28.9M Sell
79,830
-11,350
-12% -$3.8M 2.29% 18
2020
Q1 		$25.9M Buy
91,180
+9,117
+11% +$2.87M 3.11% 14
2019
Q4 		$26.7M Sell
82,063
-15,609
-16% -$4.73M 3.15% 16
2019
Q3 		$28.4M Buy
97,672
+6,403
+7% +$1.83M 3.41% 12
2019
Q2 		$26.8M Sell
91,269
-11,052
-11% -$3.04M 3.92% 12
2019
Q1 		$28M Buy
102,321
+10,778
+12% +$2.68M 4.65% 9
2018
Q4 		$20.5M Buy
91,543
+35,543
+63% +$8.34M 4% 9
2018
Q3 		$13.7M Sell
56,000
-9,000
-14% -$2.07M 2.51% 17
2018
Q2 		$13.5M Buy
65,000
+30,000
+86% +$6.37M 3.29% 13
2018
Q1 		$7.23M Sell
35,000
-5,000
-13% -$1.05M 2.93% 14
2017
Q4 		$7.59M Buy
40,000
+15,000
+60% +$2.87M 5.32% 9
2017
Q3 		$4.73M Sell
25,000
-5,000
-17% -$906K 3.34% 14
2017
Q2 		$5.23M Buy
30,000
+2,000
+7% +$336K 3.41% 10
2017
Q1 		$4.3M Buy
+28,000
New +$4.28M 2.97% 12

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

La Financiere de L'Echiquier's TMO Position: Q2 2024 in Review

La Financiere de L'Echiquier increased its Thermo Fisher Scientific (TMO) stake by 3.4% in Q2 2024, buying an estimated $2.1M and bringing the position to 111,877 shares worth $61.9M. The position accounts for 2.7% of the portfolio, ranked #12.

La Financiere de L'Echiquier first reported a position in TMO in Q1 2017 and has held it in 30 quarters since. The position peaked at $97.3M in Q2 2021. 2,544 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • La Financiere de L'Echiquier held 111,877 shares of Thermo Fisher Scientific worth $61.9M as of Q2 2024.
  • La Financiere de L'Echiquier bought 3,667 Thermo Fisher Scientific shares in Q2 2024, an estimated $2.1M.
  • Thermo Fisher Scientific made up 2.7% of La Financiere de L'Echiquier's portfolio in Q2 2024, its #12 holding.
  • La Financiere de L'Echiquier first reported a position in Thermo Fisher Scientific in Q1 2017 and has held it in 30 quarters since.
  • La Financiere de L'Echiquier's Thermo Fisher Scientific position peaked at $97.3M in Q2 2021.
  • 2,544 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on La Financiere de L'Echiquier's 13F filing for Q2 2024, filed 18 Jul 2024.